Items per page
Sort by

Send to:

Choose Destination

Results: 20


Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group.

PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015 Mar.


Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD; INSIGHT SMART, ESPRIT Study Groups; SILCAAT Scientific Committee.

J Am Heart Assoc. 2014 May 28;3(3):e000844. doi: 10.1161/JAHA.114.000844.


Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial--ANRS HB02 VAC-ADN.

Fontaine H, Kahi S, Chazallon C, Bourgine M, Varaut A, Buffet C, Godon O, Meritet JF, Saïdi Y, Michel ML, Scott-Algara D, Aboulker JP, Pol S; ANRS HB02 study group.

Gut. 2015 Jan;64(1):139-47. doi: 10.1136/gutjnl-2013-305707. Epub 2014 Feb 20.


Immunological and antiviral responses after therapeutic DNA immunization in chronic hepatitis B patients efficiently treated by analogues.

Godon O, Fontaine H, Kahi S, Meritet J, Scott-Algara D, Pol S, Michel M, Bourgine M.

Mol Ther. 2014 Mar;22(3):675-84. doi: 10.1038/mt.2013.274. Epub 2013 Dec 5.


Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group.

HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.


IL-23 and IL-12p70 production by monocytes and dendritic cells in primary HIV-1 infection.

Louis S, Dutertre CA, Vimeux L, Fery L, Henno L, Diocou S, Kahi S, Deveau C, Meyer L, Goujard C, Hosmalin A.

J Leukoc Biol. 2010 Apr;87(4):645-53. doi: 10.1189/jlb.1009684. Epub 2010 Jan 22.


Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.


[A most unusual foreign body in the cecum].

Fennich S, Sader Z, Houzé JP, Kahi S, Picard A, Chazelet C, Febvey JC.

J Chir (Paris). 2008 Nov-Dec;145(6):608-9. French.


[Chronic familial pancreatitis presenting as major pleuro-pulmonary complications].

Houzé JP, Aljundi A, Kahi S, Fennich S, Picard A.

J Chir (Paris). 2006 Jul-Aug;143(4):268-70. French. No abstract available.


Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection.

Kamga I, Kahi S, Develioglu L, Lichtner M, Marañón C, Deveau C, Meyer L, Goujard C, Lebon P, Sinet M, Hosmalin A.

J Infect Dis. 2005 Jul 15;192(2):303-10. Epub 2005 Jun 15.


Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts.

Fatoohi AF, Cozon GJ, Wallon M, Kahi S, Gay-Andrieu F, Greenland T, Peyron F.

Eur J Clin Microbiol Infect Dis. 2003 Mar;22(3):181-4. Epub 2003 Mar 4.


Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection.

Pacanowski J, Kahi S, Baillet M, Lebon P, Deveau C, Goujard C, Meyer L, Oksenhendler E, Sinet M, Hosmalin A.

Blood. 2001 Nov 15;98(10):3016-21.


[Congenital toxoplasmosis. Transitory negative serology].

Jaisson-Hot I, Wallon M, al Kurdi M, Thulliez P, Kahi S, Cozon G, Peyron F.

Presse Med. 2001 Jun 9;30(20):1001-4. French.


Early detection of cellular immunity in congenitally Toxoplasma gondii-infected children.

Kahi S, Cozon GJ, Peyron F.

Pediatr Infect Dis J. 1999 Sep;18(9):846-7. No abstract available.


A switch towards Th2 during serological rebound in children with congenital toxoplasmosis.

Kahi S, Cozon GJ, Pinon JM, Greenland T, Wallon M, Al Kurdi M, Ferrandiz J, Peyron F.

Clin Exp Immunol. 1999 Sep;117(3):524-8.


Flow cytometric quantification of Toxoplasma gondii cellular infection and replication.

Gay-Andrieu F, Cozon GJ, Ferrandiz J, Kahi S, Peyron F.

J Parasitol. 1999 Jun;85(3):545-9.


A rapid flow cytometric method to explore cellular immunity against Toxoplasma gondii in humans.

Kahi S, Cozon GJ, Greenland T, Wallon M, Gay-Andrieu F, Peyron F.

Clin Diagn Lab Immunol. 1998 Nov;5(6):745-8.


Circulating Toxoplasma gondii-specific antibody-secreting cells in patients with congenital toxoplasmosis.

Kahi S, Cozon GJ, Greenland T, Alkurdi M, Wallon M, Peyron F.

Clin Immunol Immunopathol. 1998 Oct;89(1):23-7.


[Therapeutic evolution of 63 cases of recent acute myeloblastic leukemias].

Fiere D, Bryon PA, Dechavanne M, Guyon JM, Kahi S, Revol L.

Lyon Med. 1971 Feb 14;225(3):225-8. French. No abstract available.


[Therapeutic course of 30 recent cases of acute lymphoblastic leukemia].

Fiere D, Bryon PA, Dechavanne M, Guyon JM, Kahi S, Revol L.

Lyon Med. 1971 Jan 24;225(2):109-14. French. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk